Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123353902 | 12335390 | 2 | F | 20140314 | 20160829 | 20160504 | 20160902 | EXP | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-27381BI | BOEHRINGER INGELHEIM | 51.14 | YR | M | Y | 101.61000 | KG | 20160902 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123353902 | 12335390 | 1 | PS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Oral | 22512 | 150 | MG | CAPSULE | BID | |||||||
| 123353902 | 12335390 | 2 | C | LOPRESSOR | METOPROLOL TARTRATE | 1 | Oral | 50 MG | 0 | 25 | MG | TABLET | BID | ||||||
| 123353902 | 12335390 | 3 | C | LOPRESSOR | METOPROLOL TARTRATE | 1 | Oral | 75 MG | 0 | 25 | MG | TABLET | TID | ||||||
| 123353902 | 12335390 | 4 | C | LOPRESSOR | METOPROLOL TARTRATE | 1 | Oral | 100 MG | 0 | 50 | MG | TABLET | BID | ||||||
| 123353902 | 12335390 | 5 | C | ASPIRIN. | ASPIRIN | 1 | Oral | ADULT LOW STRENGTH ; EC | 0 | 81 | MG | TABLET | QD | ||||||
| 123353902 | 12335390 | 6 | C | MULTIVITAMIN | VITAMINS | 1 | Oral | 0 | TABLET | QD | |||||||||
| 123353902 | 12335390 | 7 | C | PRINIVIL | LISINOPRIL | 1 | Oral | 0 | 10 | MG | TABLET | QD | |||||||
| 123353902 | 12335390 | 8 | C | CARDIZEM CD | DILTIAZEM HYDROCHLORIDE | 1 | Oral | SR | 0 | 120 | MG | CAPSULE | QD | ||||||
| 123353902 | 12335390 | 9 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 10 MG | 0 | 10 | MG | TABLET | QD | ||||||
| 123353902 | 12335390 | 10 | C | ZESTRIL | LISINOPRIL | 1 | Oral | 0 | 10 | MG | TABLET | QD | |||||||
| 123353902 | 12335390 | 11 | C | CENTRUM SILVER | MINERALSVITAMINS | 1 | Oral | 0 | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123353902 | 12335390 | 1 | Atrial fibrillation |
| 123353902 | 12335390 | 2 | Hypertension |
| 123353902 | 12335390 | 5 | Product used for unknown indication |
| 123353902 | 12335390 | 6 | Product used for unknown indication |
| 123353902 | 12335390 | 7 | Hypertension |
| 123353902 | 12335390 | 8 | Hypertension |
| 123353902 | 12335390 | 9 | Product used for unknown indication |
| 123353902 | 12335390 | 10 | Hypertension |
| 123353902 | 12335390 | 11 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123353902 | 12335390 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123353902 | 12335390 | Cerebrovascular accident |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123353902 | 12335390 | 1 | 20110613 | 0 |